Hesham A. Abdullah, Senior Vice President of Global Head Oncology, Research and Development at GSK and Scientific Advisory Board (SAB) Member at Linden Lake Labs, Incorporation, shared a post on LinkedIn:
“World Ovarian Cancer Day is an important reminder that, despite progress already made, many patients still face significant challenges navigating ovarian cancer, highlighting the need for continued innovation and comprehensive support.
At GSK, we’re committed to not only raising awareness of these challenges but also actively developing innovative solutions that help people with ovarian cancer live longer and live well.
Our ‘Your Cancer Is Our Challenge’ initiative revealed an overwhelming 89% of people with gynecologic cancers surveyed want to understand more about available testing options to help inform their treatment plan.
This feedback is so important, it tells us there’s a real need for clarity around how genetic and biomarker testing can help doctors identify treatment options that are personalized to each patient.
Hear more from Dr. Amina Ahmed, a leading gynecologic oncologist, as she shares her insights on the vital role of genetic and biomarker testing in gynecologic cancer care.
We see and hear patients, families and caregivers experiencing ovarian cancer. Their lived experience is the engine of our work.”
Other articles about Ovarian Cancer on OncoDaily.